Success in my Habit

Monday, July 30, 2012

India's GDP will cross the $5 trillion mark by 2020: Report

New Delhi: Business information and knowledge provider Dun & Bradstreet on Friday forecasted that India's GDP will still cross the US$ 5 trillion mark by 2020 despite the economy slowdown, in its second edition of its publication, India 2020 - economy outlook.

The study evaluates the growth of the Indian economy in the current decade based on its strengths and weaknesses.

"India is expected to be more than US$ 5 trillion (current market price) economy by FY20, and reach close to Japan (in terms of GDP in US$) as of 2010," the report said. "We expect the current phase of subdued growth to continue till FY15 before the economy moves into a high growth phase," it added.

According to the report, investment activity is expected to accelerate, which will help the Indian economy grow faster. Share of investment to GDP is expected to increase to 40.7% of GDP by FY20 from 36.6% in FY10. Infrastructure will be both a cause and a consequence of economic growth during the current decade. Share of discretionary spending is likely to rise to 70% of the private final consumption expenditure by FY20, compared to 60.0% in FY11.

Dr. Arun Singh, senior economist at Dun & Bradstreet India said in a statement: "Subdued growth in the domestic economy owing to the culmination of domestic and global factors is likely to continue till FY15, after which we expect the Indian economy to embark on a high growth phase."

Dun & Bradstreet also says that investment in physical infrastructure is likely to lead to employment generation, increased production efficiency, reduction in cost of doing business and improved standard of living. The share of the private sector in infrastructure financing is expected to increase from 39.4% in FY12 to 48. % in FY20.

Maharashtra, Gujarat, Andhra Pradesh and Tamil Nadu will be among the most progressed states in the country by FY20, while Bihar, Madhya Pradesh, Rajasthan, Odisha and Uttar Pradesh which have been considered laggard in terms of development, are expected to begin leveraging their huge potential in terms of vast natural resources and manpower.

Sunday, July 29, 2012

Kavveri Telecom acquires wireless division of WPCS of United States

Bangalore: Kavveri Technologies Americas Inc, the US subsidiary of Bangalore-based Kavveri Telecom Products, a wireless subsystem manufacturer that provides world class hardware products and solutions for the telecom, defense and space industry, has acquired the wireless communication division of Nasdaq-listed WPCS International. WPCS has operations in Lakewood, New Jersey and Hartford Connecticut.

Kavveri's strategy is to build its core wireless technology groups and establish itself as a global end to end wireless infrastructure solutions company. The buyout enhances Kavveri's market positioning both in the cellular and public safety market segments in the US.

The acquisition will provide Kavveri with a comprehensive range of wireless systems solutions including in-building for public safety and cellular applications, network solutions, mobile data, asset tracking, radio systems, video solutions, wireless infrastructure and integrated business systems.

Shivakumar Reddy, managing director, Kavveri Telecom Products said, The essence of the WPCS International Incorporated acquisition not only enhances our wireless systems solutions capabilities but will expand and strengthen our sales channels for Kavveri Group products in the US market. ''

Uma Reddy, President of the company said, Kavveri is now well positioned to take advantage of the significant growth opportunities in both public safety and cellular in building applications in the US.

Kavveri has been very bullish about inorganic growth in the last many years. The company had made several acquisitions across Europe in the past.

India Show to promote Indian investments in Sri Lanka

New Delhi: The India Show to be held on August 3-5, 2012, is being organised in Colombo, Sri Lanka. The Show considered to be “land of limitless opportunities” with participation of about 100 Indian companies, will be attended by Mr Anand Sharma, the Union Minister for Commerce and Industry, as per an official.

The event is being organised by the Confederation of Indian Industry (CII) with the support of Ministry of Commerce & Industry, Government of India, India Brand Equity Foundation (IBEF), High Commission of India and the Ceylon Chamber of Commerce, Colombo.

The India Show aims to promote Indian technology and services, and is a platform for Indian companies to showcase their excellence, and to promote Indian investments in Sri Lanka. The exhibition will be followed by a business conference. The bilateral trade between the two countries grew by 65 per cent in 2011 to reach US$ 5 billion.

Automotive, engineering, food & beverage, handicrafts, science and technology, service sectors, telecom, petroleum and natural gas, are some of the key sectors to be represented in the event.

Yamaha plans to use India as key global hub

Mumbai: Yamaha Motor of Japan is planning to use India as one of its key global hubs for motorcycles and scooters.

Mr Hiroyuki Suzuki, CEO & Managing Director, India Yamaha Motor, told Business Line that while high-end models could be exported to the Asean region and Japan, low-cost models would be the best bet for emerging nations such as Africa. The idea is to optimise the robust ancillary supplier base here which offers the best in quality and a competitive costing structure.

For the moment, Yamaha has little going for it in India from the viewpoint of market share, but Mr Suzuki said all this was set to change during the course of this decade. The company will focus on gearless scooters as part of its strategy to clock volumes, while 150cc plus motorcycles will contribute to the brand-building effort.

“The scooter market is growing very fast in India and we would like to be part of this segment with the Yamaha DNA. We will focus on young women riders initially (with the Ray) before looking at other user categories,” Mr Suzuki said.

Force to reckon with
While it is still in the process of putting its India house in order, Yamaha has been a force to reckon with in Indonesia, Thailand and Vietnam where it wrapped up last year at 4.6 million units. India’s volumes were more modest at a little over five lakh units of which exports took up a third.

The company has targeted 6.4 lakh two-wheelers this calendar where exports will account for 1.9 lakh units. The one-million-mark has been set for 2015 by which time exports will account for 20 per cent (largely to Latin America and Asia). This component is gradually expected to increase post-2015 as Yamaha will focus on producing more in India for exports to Asean and Africa.

According to Mr Suzuki, India’s ranking in the Yamaha map will climb rapidly in the coming years from its present modest standing. This will go in line with its growing importance as a global production hub which may well see the country overtake traditionally strong Yamaha markets in the Asean region. Incidentally, this is also true for Honda which believes India will become its largest two-wheeler market (ahead of Indonesia and Vietnam) from 2015-16.

Procurement base
Yamaha will also use India as one of its four regional procurement bases to source parts for its global two-wheeler operations, the others being Japan, China and Asean. Its home base, Japan, will focus on technologies, while the global operations (primarily its Asean integrated development centres) will become more proactive in product development. India will join this list in good time as an intensely competitive market will require more local R&D efforts.

Venus Remedies gets third US patent

Mumbai: Venus Remedies has secured its third US patent for its novel antibiotic product Potentox. Granted by the United States Patent and Trademark Office, the patent protects the composition and the method of treatment.

The patent provides an exclusivity period until May 2027. In addition to this new patent grant, the drug is protected by a number of other patents from across the globe including Australia, New Zealand, South Korea, South Africa and Ukraine.

The new drug is an antibiotic adjuvant entity and is considered effective in case of hospital acquired pneumoniae and febrile neutropenia infections, ouinolones or aminoglycoside resistant cases.

“We see this patent grant as recognition of the capability of not only our company but Indian pharmaceutical industry as a whole in the field of pharmaceutical research. We have already initiated for strategic tie-ups with global pharma giants,’’ said Dr Mufti Suhail Sayeed, Vice President-Venus Medical Research Centre, Venus Remedies.

Infections caused by resistant micro-organisms often fail to respond to conventional treatment, resulting in prolonged illness and greater risk of death. The drug aims to halt the development of bacterial resistance as also its spread.

The company has already been marketing the drug in India and few of the emerging markets around the globe. The product is growing with a CAGR of 50 per cent since the past three years. The company plans to have a pre-IND meeting with the US FDA for fast track approval of the product.

Japanese firms keen on Indian power sector

Hydeabad: Japanese power equipment companies and lenders are keen to work with Indian companies in all spheres of the power sector, according to a senior official from the Japanese Ministry of Economy.

Mr. Tsuneyuki "Hiro" Ito, Deputy Director in Ministry of Economy, Trade and Industry, Japan, said that there is considerable technological and engineering capability that the Japanese companies such as Toshiba, Hitachi and Mitsubishi can offer to Indian companies in the power sector.

Mr. Ito, who was in Hyderabad to speak at the power plant summit, told Business Line that lenders such as Japan International Cooperation Agency and several Japanese banks are keen to take part in some of the power projects being taken up and under implementation directly or through companies.

Already some of the Japanese companies have partnered with Indian companies such as construction major L&T and JSW for power plant equipment and they have managed to bag local orders in the areas of supercritical technology products.

"This engagement will only get stronger as some of the Japanese companies are keen to work in the entire chain of power right from equipment supplies, maintenance, and also refurbishing old plants an upgrading them," he said.

Refraining to comment on quantum of investments or the orders some of these companies are currently working on, he said that the engagement is getting stronger and given the market potential this could help engage more such Japanese companies.

Friday, July 27, 2012

FMCG companies raise ad spends in Q1

Chennai: Going by the reported numbers of three companies—Dabur, Colgate and Hindustan UniLever—it is clear that FMCG companies are increasing their ad spends.

The combined ad spend of these three companies has increased by 33.6 per cent.

These companies have been introducing new products into the market and obviously have felt a need to support them with ads and promos.

For instance, Hindustan Unilever has launched products like Axe soap bar, Fair and Lovely advanced multi vitamin, Pepsodent mouthwashes, Vaseline moisture therapy heel cream and Pureit Advanced.

Colgate has brought in a battery toothbrush and a new toothbrush called Max Fresh. Dabur has a huge range of products in healthcare and home care—from toothpastes to fruit juices and nutrition supplements.

Analysts say that most of the ads have gone to the electronic media. “FMCG contributes more than half to TV advertising but only 9% to print advertising. This is the reason why even though the FMCG companies are increasing their ad spends, the print players are faring badly in terms of ad revenue growth,” says Edelweiss Research in a report on ZEE TV’s performance.

FMCG companies raise ad spends in Q1

Chennai: Going by the reported numbers of three companies—Dabur, Colgate and Hindustan UniLever—it is clear that FMCG companies are increasing their ad spends.

The combined ad spend of these three companies has increased by 33.6 per cent.

These companies have been introducing new products into the market and obviously have felt a need to support them with ads and promos.

For instance, Hindustan Unilever has launched products like Axe soap bar, Fair and Lovely advanced multi vitamin, Pepsodent mouthwashes, Vaseline moisture therapy heel cream and Pureit Advanced.

Colgate has brought in a battery toothbrush and a new toothbrush called Max Fresh. Dabur has a huge range of products in healthcare and home care—from toothpastes to fruit juices and nutrition supplements.

Analysts say that most of the ads have gone to the electronic media. “FMCG contributes more than half to TV advertising but only 9% to print advertising. This is the reason why even though the FMCG companies are increasing their ad spends, the print players are faring badly in terms of ad revenue growth,” says Edelweiss Research in a report on ZEE TV’s performance.

BHEL commissions 5 Mw solar power plant

Chennai/ Bangalore: Bharat Heavy Electricals Ltd (BHEL) has commissioned a 5-Mw grid-connected solar power plant at Shivasamudram near Mandya. This is the single largest solar photovoltaic (PV) power plant in Karnataka.

The plant has been set up by BHEL for the state-owned power producer, Karnataka Power Corporation Limited (KPCL), at a cost of Rs 62 crore.

With the commissioning of this unit, the company has set a new record in its solar PV business in a single year, by commissioning 15 Mw of solar power plants in various parts of the country during fiscal 2011-12, marking a significant contribution to the nation’s green initiatives.

For the Shivasamudram project, BHEL’s scope of work included design, manufacture, supply, erection and commissioning of the solar power plant. In addition, BHEL will also operate and maintain the solar power plant for a period of three years.

The solar power plant is operating satisfactorily since synchronising with the main grid and DC power generated by the solar panels is converted into AC by inverters and fed into a 66 kV grid through transformers. Crystalline silicon photovoltaic (C-SI PV) technology has been used for the solar power plant, which is well-proven and has the longest operational experience across the world.

The power plant consists of arrays of photovoltaic panels made of crystalline silicon solar cells that absorb sunlight and convert it into electricity that will be fed into the main grid.

Backed by a vast experience and expertise of nearly three decades in Power Electronics & System integration, BHEL is a leading player in the field of solar photovoltaics, from Solar Cells to System Integration of SPV power plants in India.

The SPV modules are manufactured at its ultra-modern manufacturing facility located at Bangalore. An R&D unit, located in Gurgaon, supports the operations in semi-conductors and solar photovoltaics.

In line with the rapid growth in this field, BHEL is planning to augment its manufacturing facility for Solar PV Modules during the current fiscal. The company’s PV modules are certified to international standards by accredited agencies.

Starting from small applications like solar powered street lighting, rural water pumping systems, railway signaling, offshore drilling platforms, among others, BHEL has supplied and commissioned large size stand-alone as well as grid-interactive solar power plants in a number of cities and remote areas of the country.

The company’s SPV plants have enabled the people of Lakshadweep, Sagar Islands of West Bengal, Andaman & Nicobar Islands, tribal areas of Chhattisgarh, Jharkhand among others to vastly improve their quality of life.

Teva, P&G form JV to set up manufacturing facility in Gujarat

New Delhi: The US-based Procter & Gamble (P&G) and Israel's Teva Pharmaceutical Industries plan to enter India through a joint venture (JV) by setting up their first manufacturing facility at Sanand, Gujarat, with an initial investment of Rs 250 crore (US$ 44.67 million).

The manufacturing facility is planned on 15 acres and is proposed to have two separate lines, one for manufacturing Ayurvedic drugs and another for allopathic medicines. High-tech equipment and adhering to Good Manufacturing Practices (GMP) norms to make products both for Indian and overseas market will be used.

"TPI and P&G joint venture P&G Teva would set up over-the-counter (OTC) drug manufacturing facility at Sanand with an initial investment of US$ 44.67 million," according to H G Kohsia, Commissioner, Food and Drug Control Administration (FDCA), Gujarat.

"The total proposed investment in Gujarat by the venture is around Rs 500 crore (US$ 89.37 million). It would initially hire 500 people, which could go up to 1,000," Kohsia added. In addition, the proposed facility at Sanand would have high-tech equipment and will adhere to Good Manufacturing Practices (GMP) norms to make products both for Indian and overseas market, Mr Koshia said.

A memorandum of understanding (MoU) will be signed with the State Government during the Vibrant Gujarat Global Summit-2013 scheduled in January 2013. NYSE-listed Teva is the top generic pharma company with presence in 60 countries.